论文标题
通过优化倾向的路径预测蛋白质变构信号通路和功能残基
Prediction of protein allosteric signalling pathways and functional residues through paths of optimised propensity
论文作者
论文摘要
变构通常是指通过与角质部位的不同(通常远端)位点在分子的结合来调节蛋白活性的机制。变构调节自然界的无所不能及其在药物设计和筛查的潜力中,使变构无价之宝。然而,挑战仍然存在,因为很少有计算方法可以有效地预测变构位点,确定涉及变构的信号通路或有助于针对此类位点的合适分子的设计。最近,通过使用应用于能量加权原子蛋白图的网络分析,仅使用网络分析来鉴定大量多样化的蛋白质群体蛋白质及其配体方面的变构位点的成功表明。为了解决信号通路的识别,我们在这里提出了一种方法,以计算和分数优化倾向的路径,该方法将正常位点与已识别的变构位点联系起来,并鉴定对这些路径有助于的重要残基。我们使用三种良好的变构蛋白:H-RAS,CASPASE-1和3-磷酸辛酰胺依赖性激酶-1(PDK1)展示了该方法。鉴定了正构和变构位点中的关键残基,并显示出与实验结果一致的,并且还揭示了沿该途径的关键信号传导残基,从而为药物设计提供了替代目标。通过使用计算的路径分数,我们还能够区分不同的变构调节剂的活性。
Allostery commonly refers to the mechanism that regulates protein activity through the binding of a molecule at a different, usually distal, site from the orthosteric site. The omnipresence of allosteric regulation in nature and its potential for drug design and screening render the study of allostery invaluable. Nevertheless, challenges remain as few computational methods are available to effectively predict allosteric sites, identify signalling pathways involved in allostery, or to aid with the design of suitable molecules targeting such sites. Recently, bond-to-bond propensity analysis has been shown successful at identifying allosteric sites for a large and diverse group of proteins from knowledge of the orthosteric sites and its ligands alone by using network analysis applied to energy-weighted atomistic protein graphs. To address the identification of signalling pathways, we propose here a method to compute and score paths of optimised propensity that link the orthosteric site with the identified allosteric sites, and identifies crucial residues that contribute to those paths. We showcase the approach with three well-studied allosteric proteins: h-Ras, caspase-1, and 3-phosphoinositide-dependent kinase-1 (PDK1). Key residues in both orthosteric and allosteric sites were identified and showed agreement with experimental results, and pivotal signalling residues along the pathway were also revealed, thus providing alternative targets for drug design. By using the computed path scores, we were also able to differentiate the activity of different allosteric modulators.